Jie Du ’90, ’93, PhD was elected to University of the Pacific’s Board of Regents. Her term began July 1, 2021.

“It is a great honor to work with other regents who are leaders in various fields to make a difference at Pacific, my alma mater,” said Dr. Du.

She earned her master of science and her doctor of philosophy in pharmaceutical sciences from Pacific. After a successful corporate career in the pharmaceutical industry, she founded JDP Therapeutics Inc. and served as its president and CEO until it was acquired in 2019. Under Dr. Du’s leadership, JDP Therapeutics created and developed Quzyttir, and eventually obtained approval from the Food and Drug Administration. Quzyttir is a new therapeutic product for acute allergic reactions, the first innovation in that space since 1955.


Dr. Du’s experiences and success have paved the way for women and minorities in the pharmaceutical industry. She now dedicates her time to philanthropy and mentoring budding entrepreneurs in the life sciences industry.

Pacific’s Board of Regents is entrusted with final responsibility for the quality and integrity of the education provided by the University. It selects the University president, approves the mission of the University and ensures provision of adequate resources to support that mission. In addition, the board protects the University from external pressures antithetical to academic freedom and to University autonomy or integrity.

By Anne Marie H. Bergthold

Jie Du Center for Innovation and Excellence for Drug Development

Gain skills in pharmaceutical regulation, entrepreneurship and business to help you navigate the challenges associated with new ventures in drug development. The Center’s programs are open to students, alumni and industry scientists.

Learn More
Enjoy this article? Share it with your friends